Bioethics Stock Net Income
| BOTH Stock | USD 0.01 0.00 0.00% |
Bioethics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Bioethics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bioethics' valuation are provided below:Bioethics does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Bioethics |
Bioethics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioethics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioethics.
| 12/02/2025 |
| 03/02/2026 |
If you would invest 0.00 in Bioethics on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding Bioethics or generate 0.0% return on investment in Bioethics over 90 days. Bioethics is related to or competes with ABV Consulting. It intends to seek, investigate, and if warranted acquire an interest in a business opportunity More
Bioethics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioethics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioethics upside and downside potential and time the market with a certain degree of confidence.
Bioethics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioethics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioethics' standard deviation. In reality, there are many statistical measures that can use Bioethics historical prices to predict the future Bioethics' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioethics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioethics Backtested Returns
We have found three technical indicators for Bioethics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bioethics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Bioethics has perfect predictability. Overlapping area represents the amount of predictability between Bioethics time series from 2nd of December 2025 to 16th of January 2026 and 16th of January 2026 to 2nd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioethics price movement. The serial correlation of 1.0 indicates that 100.0% of current Bioethics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Bioethics reported net income of (107,183). This is 100.01% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The net income for all United States stocks is 100.02% higher than that of the company.
Bioethics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioethics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bioethics could also be used in its relative valuation, which is a method of valuing Bioethics by comparing valuation metrics of similar companies.Bioethics is currently under evaluation in net income category among its peers.
Bioethics Fundamentals
| Return On Asset | -56.39 | |||
| Current Valuation | 647.72 K | |||
| Shares Outstanding | 1.14 M | |||
| Shares Owned By Insiders | 88.53 % | |||
| Price To Book | 2,021 X | |||
| EBITDA | (59.14 K) | |||
| Net Income | (107.18 K) | |||
| Cash And Equivalents | 554 | |||
| Total Debt | 398.53 K | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (27.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Beta | 0.53 | |||
| Market Capitalization | 295.15 K | |||
| Total Asset | 734 | |||
| Net Asset | 734 |
About Bioethics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioethics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioethics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioethics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Bioethics Pink Sheet
Bioethics financial ratios help investors to determine whether Bioethics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioethics with respect to the benefits of owning Bioethics security.